Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis
| Image |  |
|---|---|
| Description | scientific article published on 07 December 2016 |
| Author/s |
author: Gavin Giovannoni |
| Publication date | December 7, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |